S100A6 and Zika virus infectious disease: Proteasome inhibitor and lysosomal acidification inhibitor were used to explore the degradation pathway of NS3 mediated by S100A6.<h4>Results</h4>ZIKV infection induced a dose- and time-dependent increase in host S100A6 expression.